Close Menu

NEW YORK ─ The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded Chembio Diagnostics $12.7 million, partly to develop a rapid, multiplex DPP Respiratory Antigen Panel point-of-care system for use during the upcoming flu season, Chembio said Wednesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.